|
π
|
International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials.
25 auth.
J. Galipeau,
M. Krampera,
J. Barrett,
F. Dazzi,
R. Deans,
Joost DeBruijn,
M. Dominici,
W. Fibbe,
A. Gee,
J. Gimble,
P. Hematti,
M. Koh,
K. Leblanc,
I. Martin,
I. Mcniece,
...
M. Mendicino,
Steve Oh,
L. Ortiz,
D. Phinney,
V. Planat,
Yufang Shi,
D. Stroncek,
S. Viswanathan,
D. Weiss,
L. SensΓ©bΓ©
|
8 |
2016 |
8
π
|
|
π
|
Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse.
10 auth.
F. van Rhee,
F. Lin,
J. Cullis,
A. Spencer,
N. Cross,
A. Chase,
...
B. Garicochea,
J. Bungey,
J. Barrett,
J. Goldman
|
8 |
1994 |
8
π
|
|
π
|
Safety, Tolerance, and Pharmacokinetics of High-Dose Liposomal Amphotericin B (AmBisome) in Patients Infected withAspergillus Species and Other Filamentous Fungi: Maximum Tolerated Dose Study
8 auth.
T. Walsh,
J. Goodman,
P. Pappas,
I. Bekersky,
D. Buell,
M. Roden,
...
J. Barrett,
E. Anaissie
|
8 |
2001 |
8
π
|
|
π’
|
Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy.
E. Sloand,
Colin O. Wu,
P. Greenberg,
N. Young,
J. Barrett
|
7 |
2008 |
7
π’
|
|
π
|
Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo.
7 auth.
E. Sloand,
S. Kim,
J. Maciejewski,
F. van Rhee,
A. Chaudhuri,
J. Barrett,
...
N. Young
|
7 |
2000 |
7
π
|
|
π’
|
Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect.
R. Childs,
E. Clave,
J. Tisdale,
M. Plante,
N. Hensel,
J. Barrett
|
7 |
1999 |
7
π’
|
|
π
|
Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia
16 auth.
K. Stringaris,
T. Sekine,
A. Khoder,
A. Alsuliman,
Bonnie Razzaghi,
Ruhena Sargeant,
J. PavlΕ―,
Gill Brisley,
H. de Lavallade,
Anushruti Sarvaria,
...
D. Marin,
S. Mielke,
J. Apperley,
E. Shpall,
J. Barrett,
K. Rezvani
|
7 |
2014 |
7
π
|
|
π
|
Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome.
9 auth.
J. Maciejewski,
D. Follmann,
R. Nakamura,
Y. Saunthararajah,
C. Rivera,
T. Simonis,
...
K. Brown,
J. Barrett,
N. Young
|
7 |
2001 |
7
π
|
|
π
|
Hematopoietic stem-cell transplantation for advanced systemic mastocytosis.
44 auth.
C. Ustun,
A. Reiter,
B. Scott,
R. Nakamura,
G. Damaj,
S. Kreil,
R. Shanley,
W. Hogan,
M. Perales,
T. Shore,
H. Baurmann,
R. Stuart,
B. Gruhn,
M. Doubek,
Jack W. Hsu,
...
E. Tholouli,
T. Gromke,
L. Godley,
L. Pagano,
A. Gilman,
E. Wagner,
T. Shwayder,
M. BornhΓ€user,
E. Papadopoulos,
A. BoΜhm,
G. Vercellotti,
M. V. van Lint,
C. Schmid,
W. Rabitsch,
V. Pullarkat,
F. Legrand,
I. Yakoub-Agha,
W. Saber,
J. Barrett,
O. Hermine,
H. Hagglund,
W. Sperr,
U. Popat,
E. Alyea,
S. Devine,
H. Deeg,
D. Weisdorf,
C. Akin,
P. Valent
|
7 |
2014 |
7
π
|
|
π¦
|
Nonβmyeloablative stem cell transplants
J. Barrett,
R. Childs
|
6 |
2000 |
6
π¦
|
|
π’
|
Coincident myelodysplastic syndrome and Tβcell large granular lymphocytic disease: clinical and pathophysiological features
8 auth.
Y. Saunthararajah,
J. Molldrem,
M. Rivera,
Ann H. Williams,
M. Stetler-Stevenson,
L. Sorbara,
...
N. Young,
J. Barrett
|
6 |
2001 |
6
π’
|
